Brian Fairchild 
Introduction
Red light therapy has moved from dermatology clinics into living rooms and wellness centers at remarkable speed. Devices ranging from handheld wands to full-body panels now promise benefits for skin, joints, muscle recovery, sleep, and, increasingly, blood pressure. The cardiovascular claims have caught the attention of researchers, and the science deserves a careful look. For anyone managing hypertension, the honest answer is this: the research is real, the early signals are interesting, and researchers lack enough evidence to make a clinical recommendation yet. However, it is also a topic worth understanding because the mechanism is legitimate and future research may change the picture.
This post covers what red light therapy is, how it may affect blood pressure and blood vessels, what the best current clinical evidence shows, who should be cautious about using it, and where it sits relative to proven approaches. For context on the full range of factors that influence blood pressure, see our article on what causes high blood pressure.
It was 150/100, this morning it was 110/79
Watch How Mark Lowered His Blood Pressure Naturally.
What Is Red Light Therapy?
Red light therapy goes by several names in clinical literature: photobiomodulation (PBM), low-level laser therapy, and low-level light therapy. All share the same basic principle: applying specific wavelengths of red or near-infrared light at low intensity to trigger biological responses in cells.
The wavelengths used in cardiovascular research typically fall between 630 and 850 nanometers. At these wavelengths, light penetrates the skin and cells absorb it through structures inside, particularly cytochrome c oxidase, an enzyme inside the mitochondria that plays a central role in energy production. When that enzyme absorbs light, it triggers a cascade: more ATP production, shifts in reactive oxygen species, and — most relevant to blood pressure — higher nitric oxide levels in blood vessel walls.
Nitric oxide is a signaling molecule that tells blood vessels to relax and widen. Several blood pressure medications target this same pathway. It is also one mechanism through which slow, deep breathing lowers blood pressure. For more on how nitric oxide functions in blood pressure regulation, see how RESPeRATE works.
What the Research Shows
The 2025 systematic review and meta-analysis
The most comprehensive look at this topic to date is a 2025 systematic review and meta-analysis by Esposito and colleagues, published in the Journal of Clinical Medicine. The researchers searched five major databases, screened 197 articles, and found four randomized controlled trials covering 229 hypertensive patients, plus five experimental animal studies. This is the first systematic review of its kind on this topic.
The pooled analysis of three RCTs found that photobiomodulation reduced systolic blood pressure by a mean of 15.87 mmHg (95% CI: −27.11 to −4.64, p=0.006). Diastolic blood pressure fell by a mean of 8.73 mmHg (95% CI: −15.19 to −2.26, p=0.008). Heart rate also fell in the one trial that measured it. Animal studies showed reductions in systolic and diastolic blood pressure alongside increases in nitric oxide levels.
Those numbers are striking. The authors were direct about the limitations, however. The researchers graded the certainty of evidence as very low across all outcomes, for both the human trials and the animal studies. All four RCTs carried a high overall risk of bias. The trials were small, used different comparison groups (some compared to sham treatment, some to standard medication, some to no treatment at all), and showed considerable heterogeneity. The authors concluded that current evidence does not yet support a clinical recommendation for photobiomodulation as a hypertension treatment.
What “very low certainty” means in this context: the signal is real and consistent across studies, but the trials are too small and too methodologically weak to be confident in the size or reliability of the effect. Larger, better-designed trials are needed before any clinical body can endorse this as a treatment.
The clinical trials in detail
All four included RCTs used laser acupuncture, applying low-power laser light to specific acupuncture points rather than broad skin surface exposure. That distinction matters. Consumer red light therapy panels, which expose large body areas to light, are not the same as the laser acupuncture protocols studied in these trials. The two approaches share a basic mechanism but differ significantly in application, dosing, and target tissue.
Trials ran between four and twelve weeks, with sessions once to three times per week. The patient populations included adults with mild to severe hypertension, with blood pressure ranging from 125/81 to 170/105 mmHg at baseline. Three of the four trials showed within-group blood pressure reductions, but only two ran the between-group comparisons needed to confirm the therapy — rather than regression to the mean or placebo — drove those reductions.
The animal data
Five experimental studies using hypertensive rat models found consistent blood pressure reductions with photobiomodulation at 660 nm, the red light wavelength most commonly studied. A 2024 study by Oishi and colleagues found that 12 weeks of red light treatment at 660 nm prevented blood pressure increases in obese rats and normalized nitric oxide levels. A 2023 study by Schiavon and colleagues found hypotensive effects in a renovascular hypertension model. Animal data cannot be directly applied to human treatment, but the consistent direction of effects across different hypertension models adds biological plausibility to the human signals.
The nitric oxide mechanism
The most thoroughly documented mechanism is nitric oxide. A 2023 review by Kashiwagi and colleagues in the journal Nitric Oxide documented the specific photobiomodulation pathways that increase NO production in vascular tissue. Red and near-infrared light releases NO that proteins in blood vessel walls store, stimulates new NO synthesis through endothelial nitric oxide synthase, and cuts the oxidative stress that would otherwise destroy NO before it can act. The result is vasodilation and reduced vascular resistance. That is a mechanistically coherent pathway — not a vague wellness claim.
It was 170/110, this morning it was 120/80
Watch how Julie Lowered her Blood Pressure Naturally.
Who Should Be Cautious
Published research generally shows red light therapy is well tolerated. None of the four RCTs reported adverse effects, though none included formal safety monitoring protocols. There are, however, several important cautions that are particularly relevant to people managing hypertension.
Photosensitizing medications
Several medications make the skin more sensitive to light. People with hypertension are among the most likely to take them. Diuretics — including hydrochlorothiazide, one of the most widely prescribed blood pressure medications — are also known photosensitizers. Certain antibiotics (tetracycline, doxycycline), some NSAIDs, some antidepressants, and some antipsychotics also fall into this category. If you take any of these, discuss red light therapy with your physician before starting. The American Heart Association recommends discussing any new supplement or therapy with your care team when managing blood pressure.
Conditions requiring medical clearance
Some conditions require physician clearance before starting red light therapy. These include active cancer or suspicious skin lesions in the treatment area, photosensitive epilepsy, systemic lupus, active thyroid conditions, and neuropathy causing reduced skin sensation. Always avoid direct eye exposure without appropriate protection, regardless of health status.
Stress and the sympathetic nervous system
Elevated blood pressure often reflects chronic sympathetic nervous system activation — the body’s stress and alert response. Red light therapy works through a cellular and vascular pathway but does not directly address the neural component of blood pressure elevation. For people whose blood pressure is significantly stress-driven, addressing that component is just as important. See our article on how stress affects blood pressure for a deeper look.
Where This Stands — and Where RESPeRATE Fits
Red light therapy for blood pressure is not ready to be recommended by any major clinical body. The evidence base consists of four small RCTs with high risk of bias and a handful of animal studies. The 2025 meta-analysis authors are explicit: rigorous, well-designed trials are needed before conclusions can be drawn. Anyone drawn to this area should approach it with caution, discuss it with their physician — especially if they take diuretics or other photosensitizing medications — and avoid substituting it for proven treatments.
What is proven is RESPeRATE. It is the only FDA-cleared non-drug device clinically proven to lower blood pressure, with more than 50 published studies behind it. Both share a nitric oxide mechanism. Elevated blood pressure often reflects chronic sympathetic nervous system activation — the body’s stress and alert response. Slow, guided breathing activates the parasympathetic nervous system, promoting nitric oxide release in blood vessel walls and reducing the vascular resistance that keeps pressure elevated. However, unlike red light therapy, RESPeRATE’s clinical evidence base is deep, its trials carry well-characterized bias risk assessments, and researchers have established the effect size. Review the full evidence at our clinical proof page.
RESPeRATE works best as part of your overall health program alongside your physician-directed treatment plan. If you are curious about red light therapy, bring it up with your doctor. In the meantime, the tools that are already proven are the right place to start.
Summary
Red light therapy works through a real, documented biological mechanism involving nitric oxide and blood vessel relaxation. The first systematic review and meta-analysis on this topic, published in 2025, found statistically significant blood pressure reductions across small clinical trials. However, researchers rated the evidence as very low certainty due to small sample sizes, high risk of bias, and methodological limitations. No major clinical body currently endorses red light therapy for blood pressure treatment.
For people managing hypertension, red light therapy may be worth watching as research develops. It is not worth substituting for proven approaches. Discuss it with your physician before starting, particularly if you take diuretics or other photosensitizing medications.
Clinically proven
Eli 
Comments